Melazyme Gets $2M Seed Fund for Precision Fermentation

Context: Melazyme was founded in 2025 and is based in the United States. The company uses precision fermentation to produce specialty proteins and pigments that are difficult or costly to synthesize chemically. Its initial focus is brazzein, a natural sweetener that is being co-developed with food and beverage partners. Parallel efforts target melanin production, a pigment with tunable UV-blocking and coloration properties for cosmetic applications. The startup's technology platform allows adjustment of functional characteristics in the fermented output, enabling tailored molecules for different end-uses. Near-term commercial activities are concentrated in the cosmetics sector, while discussions are underway with global manufacturers interested in melanin's protective and aesthetic benefits.

Key Facts: SeaX Ventures led the investment and stated that the capital will support platform development, scale up production, and advance early commercial deployments across Melazyme's target molecules portfolio. Stellaris Venture Partners and Plug and Play Ventures joined as co-investors in the round. Dr. Kid Parchariyanon, Managing Partner at SeaX Ventures, emphasized that the founding team brings proven experience in building and scaling precision fermentation companies. He also noted that the platform's design enables applications beyond a single industry, opening opportunities in consumer, industrial, and environmental sectors.

What It Means: With the new funds, Melazyme can expand its strain engineering capabilities and increase fermentation throughput to meet pilot-scale demand. The company plans to engage additional partners in the cosmetics industry to test melanin-based formulations for sunscreen and color products. Beyond cosmetics, the platform could supply bio-derived proteins for nutrition or replace petrochemical-based pigments in coatings and plastics. Investors will likely monitor progress on partnership agreements and the timing of the first commercial melanin product launch.